Streetbeat News

Earnings

JACK

Jack In The Box reported Q2 FY23 sales growth of 22.8% YoY to $395.7 million, beating consensus estimates. Adjusted EPS of $1.47 also topped the consensus of $1.22. The company raised its FY23 operating EPS guidance, and several analysts increased their price targets on the stock.

Portfolio Pulse from Lisa Levin

May 18, 2023 | 12:55 pm

CSIQ

Canadian Solar reported better-than-expected Q1 EPS results, issued Q2 revenue guidance above estimates, and raised FY23 revenue guidance, causing its shares to trade higher.

Portfolio Pulse from Benzinga Newsdesk

May 18, 2023 | 12:53 pm

GOOS

Canada Goose reported a YoY increase in Q4 financial results and issued guidance, leading to a rise in its share price.

Portfolio Pulse from Benzinga Newsdesk

May 18, 2023 | 12:51 pm

BOOT

Boot Barn Holdings issued weak financial guidance for Q1 and FY24, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

May 18, 2023 | 12:50 pm

LSPD

Lightspeed Commerce reported worse-than-expected Q4 sales results and issued 1Q24 revenue guidance below estimates, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

May 18, 2023 | 12:50 pm

BBWI

Bath & Body Works reported better-than-expected Q1 adjusted EPS results and issued guidance, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

May 18, 2023 | 12:47 pm

DLO

dLocal shares are trading higher after the company reported better-than-expected Q1 results.

Portfolio Pulse from Benzinga Newsdesk

May 18, 2023 | 12:42 pm

RAYA

Erayak Power Solution Group Inc. (NASDAQ: RAYA) reported FY22 revenue of $26.9 million, a 44.5% increase from the previous year, driven by strong sales of generator products in Europe amid the energy crisis. Net income increased by 2.4% to $3.5 million.

Portfolio Pulse from Happy Mohamed

May 18, 2023 | 12:38 pm

ZTO

ZTO Express (Cayman) shares are trading higher following the company's better-than-expected Q1 adjusted EPS results.

Portfolio Pulse from Benzinga Newsdesk

May 18, 2023 | 12:37 pm

LEGN

Legend Biotech reported Q1 losses of $(0.34) per share, beating the $(0.56) estimate by 39.29%, but sales of $36.34M missed the $37.06M estimate by 1.95%. This represents a decrease in both EPS and sales compared to the same period last year.

Portfolio Pulse from Happy Mohamed

May 18, 2023 | 12:35 pm